Ionis Pharmaceuticals Inc. Stock
Ionis Pharmaceuticals Inc. took a tumble today and lost -€2.480 (-3.970%).
The stock is one of the favorites of our community with 50 Buy predictions and 1 Sell predictions.
With a target price of 72 € there is a slightly positive potential of 19.96% for Ionis Pharmaceuticals Inc. compared to the current price of 60.02 €.
Our community identified positive and negative aspects for Ionis Pharmaceuticals Inc. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Ionis Pharmaceuticals Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Ionis Pharmaceuticals Inc. in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ionis Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals Inc. | -3.970% | -3.311% | -10.433% | 107.434% | -8.034% | 89.423% | 41.131% |
| United Therapeutics | -0.480% | -1.659% | 13.581% | 61.038% | 8.238% | 123.107% | 223.427% |
| Iovance Biotherapeutics Inc. | -2.460% | -19.517% | 44.973% | 2.335% | 41.336% | -44.715% | -87.177% |
| Ligand Pharmaceuticals | -0.550% | 0.000% | 13.665% | 83.000% | 10.241% | 191.773% | 40.607% |
Comments
Ionis Pharmaceuticals (IONS) had its price target raised by Leerink Partners from $102.00 to $104.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (IONS) had its price target raised by Piper Sandler from $87.00 to $100.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (IONS) had its "buy" rating reaffirmed by Needham & Company LLC.
Show more
Ratings data for IONS provided by MarketBeat